Clinical Trial

« Back to List

CLL 02

Posted by: Fred J. Kudrik, MD, Principal Investigator | Posted Date: August 01, 2011

Status: OPEN - IIT
Research Hotline: 803-461-3708

Details: A Phase I/II Study of Fludarabine, Rituximab, and Lenalidomide in Minimally Treated and Untreated Patients with Chronic Lymphocytic Leukemia

This clinical trial is being offered at the following location: South Carolina Oncology Associates


Bookmark and Share